Clinical Trial Update: Efficacy Study of Daily Pro-Omega LDL for Low-Density Lipoprotein Cholesterol and Triglyceride Reduction [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating Daily Pro-Omega LDL for lowering LDL cholesterol and triglycerides has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mixed Hyperlipoproteinemia

Drugs mentioned

• Pro-Omega LDL

Snippet

Sponsor: Nordic Pharma, USA | Conditions: Mixed Hyperlipoproteinemia | Phase 4 | Status: WITHDRAWN